1 / 9

New FDA Approved Drugs-2024: Understanding Trends & Advances

New FDA Approved Drugs in 2024 and those awaiting approvals are going to create revolution in healthcare by focusing on treating life-altering medical conditions.

Edwina4
Télécharger la présentation

New FDA Approved Drugs-2024: Understanding Trends & Advances

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Elementary School Presents New FDA Approved Drugs & Devices to Watch for in 2024

  2. Witness how the new medical innovations promise to transform lives and offer new hope to those suffering from various ailments.

  3. Toripalimab-tpzi: Approved for Nasopharyngeal Carcinoma, Melanoma, Urothelial Carcinoma • Inventor: Shanghai Junshi Biosciences • Approval Date: October 27, 2023 • Eli Lily’s Zepbound (tirzepatide): Approved for Chronic Obesity • Mechanism: GLP 1 Receptors to Reduce Hunger • Approval Date: November 8, 2023

  4. iDose TR, an eye implant: Reduces Intraocular Pressure (IOP) • FDA Approval Date: December 14, 2023 • Availability: First quarter of 2024 • Zelsuvmi: Topical Antiviral Gel for Molluscum Contagiosum • Maker: Ligand Pharmaceuticals • FDA Approval Date: January 5, 2024

  5. Lifileucel: Advanced Melanoma Treatment (Awaiting Approval) • First Cell Therapy for Melanoma • Inventeor: Iovance Biotherapeutic • Elevidys: Gene Therapy for DMD • Approval Date: June 2023 • Inventor: Sarepta Therapeuticals INC.

  6. FordadistrogeneMovaparvovec: Gene Therapy for DMD (Expected approval in 2024) • Maker: Pfizer • Resmetirom: Treatment for Liver Fibrosis • FDA Priority Review - PDUFA Date: March 14, 2024 • Manufacturer: Madrigal Pharmaceuticals

  7. Crovalimab for Paroxysmal Nocturnal Hemoglobinuria (PNH) • Submitted by Chugai Pharmaceutical Co., Ltd • Merck’s Sotatercept for Pulmonary Arterial Hypertension (PAH) • Awaiting FDA Approval in 2024 • Orchard Therapeutics’ Libmeldy: Stem Cell Therapy for MLD • Under FDA Approval Process

  8. Responsibility for all Responsibility falls on Pharma Companies, Physicians, Patients, and Families to ensure drug and device safety.

  9. For a flawless medical record Contact Phone: +1-404-382-5426 Mail: sales@lezdotechmed.com Web: us.lezdotechmed.com/ Contact https://us.lezdotechmed.com/

More Related